You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 108 No. 4, April 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (43)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Bilateral Diffuse Uveal Melanocytic Proliferation in Patients With Occult Carcinoma

J. Donald M. Gass, MD; Richard G. Gieser, MD; C. P. Wilkinson, MD; Donald E. Beahm, MD; Scott E. Pautler, MD

Arch Ophthalmol. 1990;108(4):527-533.


Abstract

• The development of multiple, round or oval, subtle, red patches at the level of the pigment epithelium in the posterior ocular fundus and their striking early hyperfluorescence angiographically are characteristic features of the bilateral diffuse uveal melanocytic proliferation syndrome. They may be accompanied by severe visual loss and may antedate the appearance of multiple melanocytic tumors, retinal detachment, and cataract in these patients with occult systemic carcinomas. These hyperfluorescent patches are caused by focal damage to the pigment epithelium overlying an intact choriocapillaris and diffuse benign nonpigmented uveal melanocytic infiltration of the outer choroid. We suggest that outer retinal damage may not be primarily caused by melanocytic proliferation, but rather by toxic and immune factors generated by interaction between a systemic carcinoma and congenital melanocytosis of the uveal tract. We report the longest survivor of this disorder to date (102 months).



Author Affiliations

From the Departments of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Fla (Dr Gass); Loyola University of Chicago Stritch School of Medicine, Maywood, Ill (Dr Gieser); Dean A. McGee Eye Institute, Oklahoma City, Okla (Dr Wilkinson); University of Kansas, Kansas City (Dr Beahm); and University of South Florida, Tampa (Dr Pautler).


Footnotes

Accepted for publication December 29, 1989.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Unilateral diffuse uveal melanocytic proliferation (DUMP)
Reddy and Finger
Br J Ophthalmol 2007;91:1726-1727.
FULL TEXT  

Uveal and Cutaneous Involvement in Paraneoplastic Melanocytic Proliferation
Singh et al.
Arch Ophthalmol 2003;121:1637-1640.
FULL TEXT  

Case 2-2002- A 58-Year-Old Woman with Unilateral Loss of Vision and Postmenopausal Bleeding
D'Amico and Dryja
NEJM 2002;346:189-195.
FULL TEXT  

Leopard-Spot Pattern of Yellowish Subretinal Deposits in Central Serous Chorioretinopathy
Iida et al.
Arch Ophthalmol 2002;120:37-42.
ABSTRACT | FULL TEXT  

Bilateral optic neuropathy with IgG{kappa} multiple myeloma improved after myeloablative chemotherapy
Lieberman et al.
Neurology 1999;52:414-414.
ABSTRACT | FULL TEXT  

Early Lesions of Bilateral Diffuse Melanocytic Proliferation
Leys et al.
Arch Ophthalmol 1991;109:1590-1594.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.